NEAT1/hsa‐mir‐98‐5p/MAPK6 axis is involved in non–small‐cell lung cancer development
Authors:
- 14 December 2018
- journal article
- research article
- Published by Wiley in Journal of Cellular Biochemistry
- Vol. 120 (3) , 2836-2846
Abstract
Long noncoding RNAs (lncRNAs) or microRNAs belong to the two most important noncoding RNAs and they are involved in a lot of cancers, including non–small‐cell lung cancer (NSCLC). Therefore, currently, we focused on the biological and clinical significance of lncRNA nuclear enriched abundant transcript 1 (NEAT1) and hsa‐mir‐98‐5p in NSCLC. It was observed that NEAT1 was upregulated while hsa‐mir‐98‐5p was downregulated respectively in NSCLC cell lines compared to human normal lung epithelial BES‐2B cells. Inhibition of NEAT1 can suppress the progression of NSCLC cells and hsa‐mir‐98‐5p can reverse this phenomenon. Bioinformatics search was used to elucidate the correlation between NEAT1 and hsa‐mir‐98‐5p. Additionally, a novel messenger RNA target of hsa‐mir‐98‐5p, mitogen‐activated protein kinase 6 (MAPK6), was predicted. Overexpression and knockdown studies were conducted to verify whether NEAT1 exhibits its biological functions through regulating hsa‐mir‐98‐5p and MAPK6 in vitro. NEAT1 was able to increase MAPK6 expression and hsa‐mir‐98‐5p mimics can inhibit MAPK6 via downregulating NEAT1 levels. We speculated that NEAT1 may act as a competing endogenous lncRNA to upregulate MAPK6 by attaching hsa‐mir‐98‐5p in lung cancers. Taken these together, NEAT1/hsa‐mir‐98‐5p/MAPK6 is involved in the development and progress in NSCLC. NEAT1 could be recommended as a prognostic biomarker and therapeutic indicator in NSCLC diagnosis and treatment.Keywords
This publication has 37 references indexed in Scilit:
- Serum long non coding RNA MALAT-1 protected by exosomes is up-regulated and promotes cell proliferation and migration in non-small cell lung cancerBiochemical and Biophysical Research Communications, 2017
- Long noncoding RNA NEAT1 is an unfavorable prognostic factor and regulates migration and invasion in gastric cancerJournal of Cancer Research and Clinical Oncology, 2016
- Unique features of long non-coding RNA biogenesis and functionNature Reviews Genetics, 2015
- Therapeutic Targeting of microRNAs in Cancer: Future PerspectivesDrug Development Research, 2015
- A novel role for atypical MAPK kinase ERK3 in regulating breast cancer cell morphology and migrationCell Adhesion & Migration, 2015
- miR-98 suppresses melanoma metastasis through a negative feedback loop with its target gene IL-6Experimental & Molecular Medicine, 2014
- Long Noncoding RNA in Prostate, Bladder, and Kidney CancerEuropean Urology, 2014
- Atypical mitogen-activated protein kinases: Structure, regulation and functionsBiochimica et Biophysica Acta (BBA) - Molecular Cell Research, 2007
- Nuclear Export of ERK3 by a CRM1-dependent Mechanism Regulates Its Inhibitory Action on Cell Cycle ProgressionJournal of Biological Chemistry, 2003
- Rapid Turnover of Extracellular Signal-Regulated Kinase 3 by the Ubiquitin-Proteasome Pathway Defines a Novel Paradigm of Mitogen-Activated Protein Kinase Regulation during Cellular DifferentiationMolecular and Cellular Biology, 2003